Rapport Therapeutics, Inc. financial data

Symbol
RAPP on Nasdaq
Location
1325 Boylston Street, Suite 401, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.22K %
Debt-to-equity 4.73 %
Return On Equity -30 % -149%
Return On Assets -28.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.5M shares -0.22%
Common Stock, Shares, Outstanding 36.5M shares -0.22%
Common Stock, Value, Issued 37K USD +2.78%
Weighted Average Number of Shares Outstanding, Basic 35.4M shares +232%
Weighted Average Number of Shares Outstanding, Diluted 35.4M shares +232%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 75M USD +44.6%
General and Administrative Expense 26.8M USD +33.4%
Operating Income (Loss) -102M USD -41.8%
Nonoperating Income (Expense) 13.5M USD +3.17%
Net Income (Loss) Attributable to Parent -88.3M USD -40.1%
Earnings Per Share, Basic 7 USD/shares +55.9%
Earnings Per Share, Diluted 7 USD/shares +55.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 55.1M USD -50%
Cash, Cash Equivalents, and Short-term Investments 260M USD -22.5%
Assets, Current 270M USD -20.7%
Property, Plant and Equipment, Net 3.17M USD -8.69%
Operating Lease, Right-of-Use Asset 11M USD +524%
Other Assets, Noncurrent 1.03M USD +447%
Assets 285M USD -17.5%
Accounts Payable, Current 3.18M USD +69.4%
Employee-related Liabilities, Current 3.14M USD +83.5%
Accrued Liabilities, Current 6.94M USD +25.9%
Liabilities, Current 11.9M USD +46.7%
Operating Lease, Liability, Noncurrent 10.1M USD +805%
Liabilities 22M USD +139%
Accumulated Other Comprehensive Income (Loss), Net of Tax -76K USD +58.5%
Retained Earnings (Accumulated Deficit) -175M USD -102%
Stockholders' Equity Attributable to Parent 264M USD
Liabilities and Equity 285M USD -17.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 36.5M shares -0.22%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -88.2M USD -47.2%
Property, Plant and Equipment, Gross 4.64M USD +17.1%
Operating Lease, Liability, Current 1.76M USD +150%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 14.8M USD +86.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%